التفاصيل البيبلوغرافية
| العنوان: |
Enzyme-linked immunosorbent assay for detecting anti-pertussis toxin antibody in mouse. |
| المؤلفون: |
Gi Sub Choi, Dong Ho Huh, Seung Beom Han, Dong Ho Ahn, Kyu Ri Kang, Ji Ahn Kim, Bo Mi Choi, Hea Ryun Kim, Jin Han Kang |
| المصدر: |
Clinical & Experimental Vaccine Research; Jan2019, Vol. 8 Issue 1, p64-69, 6p |
| مصطلحات موضوعية: |
ENZYME-linked immunosorbent assay, PERTUSSIS toxin, BORDETELLA pertussis |
| مستخلص: |
Purpose: Although the DTaP and Tdap vaccines used to prevent pertussis have been used for a long time, there is no standard method for measuring pertussis antigens. Therefore, this preliminary study was conducted to develop an enzyme-linked immunosorbent assay method using an animal model for measuring antibodies against pertussis toxin, the most important pertussis pathogenic antigen, in the sera of vaccinated mice. Materials and Methods: Bordetella pertussis Tohama phase I was cultured for 24-30 hours, and then pertussis toxin was purified from the culture medium by chromatography. Purified pertussis toxin was diluted in phosphate-buffered saline-coating buffer, and 100 μL of diluted pertussis toxin was added to each well and reacted at room temperature for 4 hours. Positive serum was diluted to 1/1,250-1/80,000 and negative serum was diluted to 1/50 to determine the coating concentration with the optimal signal/noise ratio. Optimal test conditions were confirmed from the dilution factors of the secondary antibody and streptavidin horseradish peroxidase (SA-HRP). Results: Optimal conditions were as follows: 4 μg/mL for coating antigen; 1/40,000 for secondary antibody; and 1/1,000 for the SA-HRP dilution factor. Comparison of the sera obtained from mice treated with a developing vaccine and commercial vaccine with National Institute for Biological Standard and Control standard serum under the established conditions showed the following results: 1,300.62, 534.94, and 34.85, respectively. Conclusion: The method developed in this study is suitable for measuring anti-pertussis toxin antibodies and may be applicable for clinical sample analysis or indirect diagnosis of pertussis. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical & Experimental Vaccine Research is the property of Korean Vaccine Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder